Search

Displaying results 8361 - 8370 of 10000 in total
  1. Drug

    Hemoglobin crosfumaril

    go.drugbank.com/drugs/DB13864
    Experimental

    Hemoglobin in which the alpha-subunit are cross-linked intramolecularly.

    Synonyms: Hemoglobin A0 (human alpha2 beta2 tetrameric subunit), alpha-chain 99,99'-diamide with (E)-2-butenoic acid
  2. Drug

    Diclofop-methyl

    go.drugbank.com/drugs/DB13918
    Experimental

    Herbicide for control of wild oat & foxtails in cereal crops.

  3. Drug

    UX053

    go.drugbank.com/drugs/DB18558
    Investigational

    UX053 is an mRNA encoding the human glycogen debranching enzyme.

  4. Drug

    LY-2183240

    go.drugbank.com/drugs/DB17035
    Experimental

    LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037]

    Synonyms: 5-(biphenyl-4-ylmethyl)-n,n-dimethyl-1h-tetrazole-1-carboxamide, 1h-tetrazole-1-carboxamide, 5-((1,1'-biphenyl)-4-ylmethyl)-n,n-dimethyl-
  5. Drug

    Tamrintamab pamozirine

    go.drugbank.com/drugs/DB17222
    Investigational

    Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.

  6. Drug

    Pumosetrag

    go.drugbank.com/drugs/DB12402
    Investigational

    Pumosetrag has been used in trials studying Gastroesophageal Reflux Disease.

  7. Drug

    TN-301

    go.drugbank.com/drugs/DB32867
    Experimental

    TN-301 is a small-molecule histone deacetylase 6 inhibitor.

  8. Drug

    GA31

    go.drugbank.com/drugs/DB32871
    Experimental

    GA31 is an 31-amino acid TREM-1 inhibitory peptide.

  9. Drug

    Crobenetine

    go.drugbank.com/drugs/DB21095
    Investigational

    Crobenetine is under investigation in clinical trial NCT02273466 (Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects).

  10. Drug

    Dalzanemdor

    go.drugbank.com/drugs/DB21549
    Investigational

    Dalzanemdor is under investigation in clinical trial NCT05655520 (A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease).